Guanhao Biotech Co., Ltd. (300238.SZ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	386.4M	387.7M	377.5M	404.2M	377.3M
Cost of Revenue	88.7M	88.7M	77.5M	84.4M	89.6M
Gross Profit	297.7M	299.1M	300.0M	319.8M	287.7M
Operating Expenses
R&D Expense	41.2M	41.0M	36.2M	44.5M	50.5M
SG&A Expense	—	—	—	—	—
General & Admin Expense	58.4M	57.2M	57.2M	55.4M	53.9M
Selling & Marketing Expense	166.8M	160.9M	157.5M	166.5M	156.4M
Other Expenses	—	—	—	—	—
Total Operating Expenses	277.7M	270.0M	257.4M	276.1M	270.6M
Cost and Expenses	366.4M	358.6M	334.9M	360.5M	360.2M
Operating Income (EBIT)	23.3M	30.5M	28.2M	34.0M	(292.0M)
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	18.7M	27.3M	28.0M	32.1M	(292.6M)
Income Tax Expense	11.4M	12.5M	11.4M	11.0M	35.1M
Bottom Line
Net Income	19.6M	24.3M	27.4M	31.0M	(307.8M)
Earnings from Cont. Ops	7.3M	14.8M	16.6M	21.1M	(326.6M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	19.6M	24.3M	27.4M	31.0M	(307.8M)
Per Share
Basic EPS	CN¥0.08	CN¥0.09	CN¥0.10	CN¥0.12	(CN¥1.16)
Diluted EPS	CN¥0.08	CN¥0.09	CN¥0.10	CN¥0.12	(CN¥1.16)
Revenue Per Share	CN¥1.52	CN¥1.43	CN¥1.38	CN¥1.56	CN¥1.42
Shares
Basic Shares Outstanding	254.1M	270.5M	274.2M	258.4M	265.4M
Diluted Shares Outstanding	254.1M	270.5M	274.2M	258.4M	265.4M
Profitability Metrics
EBITDA	—	52.3M	49.8M	61.5M	(260.4M)
D&A	—	21.8M	21.6M	27.5M	31.6M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026